Pulling SEC filings + quote and writing the call…

EASTERN CO
Next earnings Aug 3, 2026 · consensus $0.68 EPS, $74.4M rev
Last earnings +1.6% on 2026-05-12
Shrinking sales, halved cash flow and 50% steel/aluminum tariffs meet a full 24.9x P/E — the earnings 'rebound' is base-effect, not momentum.
Revenue $249M · FY2026
It screens cheap (~43% below fair value), but the weak fundamentals are why — more potential value trap than bargain.
Eastern's headline looks like a turnaround — net income up 183.6% to $7.13M and EPS up 185.4% to $1.17 — but that comparison flatters off a FY2024 loss of -$8.53M, not real growth. The operating engine is going the wrong way: revenue fell 8.7% to $249M, gross profit dropped 15.3%, operating income was cut nearly in half (-47.0% to $10.7M), and margins are thin across the board (22.9% gross, 4.3% operating, 2.9% net, 5.7% ROE). Management's own MD&A confirms the softness — Q4 sales fell from $66.7M to $57.5M and backlog shrank from $89.2M to $81.1M on 'decreased orders for returnable transport packaging products,' so the order book points to more weakness, not a bottom. Note also the MD&A reports continuing-ops net income of just $6.0M / $0.98 per diluted share versus the $7.13M / $1.17 XBRL total, meaning the cleaner operating EPS is lower still.
The cash story reinforces the caution: operating cash flow was more than halved (-54.3% to $8.87M) and cash on hand fell 47.1% to just $7.41M, even as the company kept paying $2.68M in dividends and spent $3.73M on buybacks. Capex was slashed 59.1% to $3.97M — well below the $6.59M depreciation charge — which supports near-term cash but signals under-investment if sustained. The balance sheet is the one genuine strength: liabilities/equity of just 0.74x, $33.9M long-term debt with zero current maturities, and a 3.6x current ratio ($99.3M vs $27.6M) give the company staying power.
Is EML a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue | $247M | $279M | $259M | $273M | $249M |
| Gross profit | $48.1M | $58.6M | $61.8M | $67.3M | $57.0M |
| Operating income | $13.5M | $14.2M | $17.0M | $20.1M | $10.7M |
| Net income | $5.41M | $12.3M | $8.59M | -$8.53M | $7.13M |
| Diluted EPS | $1.76 | $1.97 | $1.37 | -$1.37 | $1.17 |
| Net margin | 2.2% | 4.4% | 3.3% | -3.1% | 2.9% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Reg FD disclosure — investor presentation/press release furnished, no financials
Q1 FY2026 10-Q (period ended Apr 4, 2026); profitability recovering YoY
Q1 FY2026 10-Q (period ended Apr 4, 2026); profitability recovering YoY
Annual meeting vote results: directors elected, routine proposals ratified
Annual meeting vote results: directors elected, routine proposals ratified
Annual-meeting proxy: director slate, say-on-pay, auditor ratification
10-K amendment (Part III / exhibit correction), no financial restatement
Amendment to a prior 8-K; supplemental exhibit/correction
Amendment to a prior 8-K; supplemental exhibit/correction
Sources: SEC EDGAR (CIK 0000031107, latest 10-Q filed 2026-05-12) · EODHD · Proprietary analysis · as of 7/3/2026, 3:41:19 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 11:41 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 10 open-market buys · 0 sales
| 2026-06-16-05:00 | EVERETS JOHN Director | Buy | 1.31K @ $21.40 | $28.0K |
| 2026-06-16-05:00 | Galbato Chan Director | Buy | 940.00 @ $21.40 | $20.1K |
| 2026-06-16-05:00 | MITAROTONDA JAMES A Director | Buy | 1.68K @ $21.40 | $35.9K |
| 2026-06-16-05:00 | Scott Peggy Director | Buy | 1.18K @ $21.40 | $25.2K |
| 2026-06-16 | DiSanto Frederick D. Director | Buy | 1.00K @ $21.25 | $21.3K |
| 2026-06-15 | DiSanto Frederick D. Director | Award | 1.07K @ $21.40 | $22.9K |
| 2026-06-12 | DiSanto Frederick D. Director | Buy | 1.00K @ $20.96 | $21.0K |
| 2026-06-11 | DiSanto Frederick D. Director | Buy | 1.00K @ $21.25 | $21.3K |
| 2026-06-05-05:00 | MITAROTONDA JAMES A Director | Buy | 3.74K @ $21.73 | $81.2K |
| 2026-06-05 | DiSanto Frederick D. Director | Buy | 288.00 @ $21.50 | $6.19K |
| 2026-06-04-05:00 | MITAROTONDA JAMES A Director | Buy | 1.92K @ $21.58 | $41.5K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median